Testing for new oral anticoagulants with LA-resistant Russells viper venom reagents. An in vitro study

Thrombosis and Haemostasis

Volumn 109, Issue 4, 2013, Pages 762-765

  Exner, Thomas ^a   Ellwood, Lisa ^a   Rubie, Jenny ^a   Barancewicz, Aileen ^a  

^a Haematex Research Pty Ltd   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APIXABAN; BLOOD CLOTTING FACTOR; DABIGATRAN; EDOXABAN; LUPUS ANTICOAGULANT; RIVAROXABAN; VIPER VENOM;

BLOOD CLOTTING TIME; CALIBRATION; DOSE RESPONSE; HUMAN; LETTER; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ADMINISTRATION, ORAL; ANIMALS; ANTICOAGULANTS; BLOOD COAGULATION; CALIBRATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FACTOR XA; LUPUS COAGULATION INHIBITOR; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS;

EID: 84875933929     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH12-11-0842     Document Type: Letter

References (9)

1. Ten Cate H. Monitoring new oral anticoagulants, managing thrombosis, or both? Thromb Haemost 2012; 107: 803-805.
2. Lindahl TL, Baghaei F, Faberberg Blixter I, et al. Effects of the oral, direct thrombin inhibitor dabi-gatran on five common coagulation assays. Thromb Haemost 2011; 105: 371-378.
3. Hillarp A, Bahaei F, Faberberg Blixter I, et al. Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays. J Thromb Haemost 2011; 9: 133-139.
4. Harenberg J, Marx S, Erdle S, et al. Determination of the anticoagulant effects of new oral anticoagulants: an unmet need. Expert Rev Hematol 2012; 5: 107-113.
5. Pengo V, Tripodi A, Reber G, et al. Update of the guidelines for lupus anticoagulant detection. J Thromb Haemost 2009; 10: 1737-1740.
6. Douxfils J, Mullier F, Robert S, et al. Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etixylate. Thromb Haemost 2012; 107: 985-997.
7. Favaloro EJ, Mirochnik O, McDonald D. Functional activated protein C resistance assays: correlation with factor V DNA analysis is better with dRVVT than with APTT based assays. Br J Biomed Sci 1999; 56: 23-33.
8. Rylatt DB, Hohnen-Behrens C, Pilgrim RL, et al. Detecting APC-resistant factor V: a functional method without plasma dilution. Blood Coagul Fibrinolysis 1999; 10: 359-366.
9. Haas FJ, van Sterckenburg-Kamp BM, Scheepers HA. A protein C pathway screening test for the detection of APC resistance and protein C or S deficiencies. Semin Thromb Hemost 1998; 24: 355-362.